Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Curevac N.V. (CVAC)

Curevac N.V. (CVAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Curevac N.V. Friedrich-Miescher-Strasse 15 Tubingen 2M 72076 DEU

www.curevac.com Employees: 1,172 P: 49-70-71988-30 F: 719-883-1101

Description:

CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

Key Statistics

Overview:

Market Capitalization, $K 557,461
Enterprise Value, $K 121,891
Shares Outstanding, K 223,880
Annual Sales, $ 58,180 K
Annual Net Income, $ -281,580 K
Last Quarter Sales, $ 543,090 K
Last Quarter Net Income, $ 371,710 K
EBIT, $ 151,300 K
EBITDA, $ 176,610 K
60-Month Beta 2.61
% of Insider Shareholders 2.15%
% of Institutional Shareholders 17.26%
Float, K 219,067
% Float 97.85%
Short Volume Ratio 0.58

Growth:

1-Year Return -53.73%
3-Year Return -94.36%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.65 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm 0.55
EPS Growth vs. Prev Qtr 585.29%
EPS Growth vs. Prev Year 787.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CVAC Ratios

Ratio
Price/Earnings ttm 4.55
Price/Earnings forward 4.08
Price/Earnings to Growth 0.21
Return-on-Equity % 21.98%
Return-on-Assets % 15.72%
Profit Margin % -483.98%
Debt/Equity 0.00
Price/Sales 9.62
Price/Cash Flow N/A
Price/Book 0.70
Book Value/Share 3.56
Interest Coverage -103.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar